Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer
OVER-CRF
Feasibility of an Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer on Cancer-related Fatigue: a Pilot RCT
1 other identifier
interventional
40
1 country
1
Brief Summary
In Italy, the incidence of lung cancer for the year 2020 has been estimated at about 41.000 new diagnoses. Patients with lung cancer experience debilitating symptoms caused by the disease itself and cancer treatments, such as dyspnea and fatigue, which reduce physical function and quality of life (QoL). It is estimated that 90% of patients undergoing chemotherapy and 57% of patients undergoing lung resection suffer of Cancer-Related Fatigue (CRF). Previous studies have shown that educational interventions and aerobic and resistance exercise are effective in improving CRF and QoL in patients with lung cancer. However, to date the optimal dose, mode and timing to deliver the intervention during the care pathway for lung cancer patients is unknown. Tolerability and frequency of cancer treatment could be a barrier to adherence to the intervention. Therefore, this study aims to evaluate the feasibility of a rehabilitation intervention aimed at improving CRF with respect to timing of delivery: early vs delayed rehabilitation in lung cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Feb 2023
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2023
CompletedFirst Submitted
Initial submission to the registry
September 17, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 2, 2025
March 1, 2025
1.8 years
September 17, 2023
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility - Adherence rate to the outpatient RP sessions
The number of patients adhering to at least 70% of outpatient RP sessions scheduled for the relative allocation group will be recorded.
At 3 and 6 months after baseline
Secondary Outcomes (9)
Recruitment rate
At baseline
Dropout rate
At 3 and 6 months after baseline
Cancer-related fatigue (CRF)
At baseline, at 3, 6, and 12 months after baseline
Quality of life (QoL)
At baseline, at 3, 6, and 12 months after baseline
Physical performance
At baseline, at 3 and 6 months after baseline
- +4 more secondary outcomes
Study Arms (2)
Early pulmonary rehabilitation (RP)
EXPERIMENTALRP immediately after enrollment.
Delayed pulmonary rehabilitation (RP)
EXPERIMENTALRP after 3 months after enrollment.
Interventions
The RP intervention consists in 8 sessions supervised by the physiotherapist weekly or biweekly and 2 therapeutic education group meetings on the importance of exercise and CRF management, over the 3 months of intervention. The RP comprise exercise program performed autonomously at home. Both the outpatient and the autonomously home-based exercise sessions comprise aerobic, resistance and respiratory exercise. The exercise program is individualized and can be delivered in telerehabilitation.
Eligibility Criteria
You may qualify if:
- Newly diagnosed of stage II and III lung cancer (NSCLC) candidates for anticancer therapies (chemotherapy, radiotherapy, immunotherapy, or combinations thereof), associated or not with surgery. In the last case, patients will be included at least 30 days after surgery.
- Prognosis ≥ 12 months
- At least 18 years old
- Recruited from the pneumology, oncology, radiotherapy, and physical medicine and rehabilitation unit of the Azienda Unità Sanitaria Locale - IRCCS of Reggio Emilia
- Willing and able to give written informed consent
You may not qualify if:
- Clinical disorders that contraindicate participation in a moderate exercise program (e.g. preexisting severe physical disabilities, major cognitive or sensory deficits, severe psychiatric disorders, language barrier, etc.).
- NSCLC stage IV
- Patients who are candidates for surgery alone
- Patients who are candidates for neoadjuvant therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
Reggio Emilia, Reggio Emilia, 42123, Italy
Related Publications (1)
Fugazzaro S, Mainini C, Pecorari A, Denti M, Galavotti MB, Messori M, Costi S, Ciammella P, Falco F, Zanelli F, Cavuto S, Bressi B. Feasibility of an early versus delayed rehabilitation intervention in patients with lung cancer on cancer-related fatigue: a pilot RCT. Future Oncol. 2026 Jan 6:1-10. doi: 10.1080/14796694.2025.2607632. Online ahead of print.
PMID: 41496492DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefania Fugazzaro, Dr.
Azienda USL Reggio Emilia - IRCCS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The randomization will be done online directly from Smarty, the software that will manage the eCRF for collecting of the study data. Furthermore, outcomes will be assessed blindly by staff involved in the research project who do not directly deliver the intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2023
First Posted
September 22, 2023
Study Start
February 28, 2023
Primary Completion
December 12, 2024
Study Completion
December 31, 2025
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share